Andrews T M, Anderson I M
Oxford Learning Disability NHS Trust, Headington, UK.
J Psychopharmacol. 1998;12(2):155-60. doi: 10.1177/026988119801200207.
We gave the indirect 5-HT agonist, D-fenfluramine (30 mg), the 5 -HT antagonist methysergide (2 mg) and placebo to 11 patients with an anxiety disorder and 12 controls in a double-blind, balanced-order, cross-over design. Compared to controls, patients had significantly higher anxiety ratings, were slower in naming colours in computerized Stroop tests and showed greater interference for anxiety-related words. Patients tended to have a lower critical flicker fusion threshold (CFFT) than controls and in the subjects taken as a whole there was a significant inverse correlation between CFFT and Spielberger state (r=-0.54, p<0.01) and trait anxiety (r=-0.55, p<0.01). Neither drug had significant effects on anxiety ratings or on Stroop interference. D-Fenfluramine significantly increased CFFT (p < 0.02) and methysergide non-significantly reduced CFFT with no significant differences between patients and controls. 5-HT may be involved in lower-level visual information processing but we found no evidence for its direct involvement in the attentional bias for anxiety-related information in the emotional Stroop.
我们采用双盲、平衡顺序、交叉设计,给11名焦虑症患者和12名对照者服用间接5-羟色胺(5-HT)激动剂右芬氟拉明(30毫克)、5-HT拮抗剂麦角酰二乙胺(2毫克)和安慰剂。与对照者相比,患者的焦虑评分显著更高,在计算机化的斯特鲁普测试中命名颜色的速度较慢,并且对与焦虑相关的词语表现出更大的干扰。患者的临界闪烁融合阈值(CFFT)往往低于对照者,并且在作为一个整体的受试者中,CFFT与斯皮尔伯格状态焦虑(r=-0.54,p<0.01)和特质焦虑(r=-0.55,p<0.01)之间存在显著的负相关。两种药物对焦虑评分或斯特鲁普干扰均无显著影响。右芬氟拉明显著提高了CFFT(p<0.02),麦角酰二乙胺非显著降低了CFFT,患者和对照者之间无显著差异。5-HT可能参与较低水平的视觉信息处理,但我们没有发现其直接参与情绪斯特鲁普中对与焦虑相关信息的注意偏向的证据。